PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 74 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,382,000 | +8.4% | 7,208,139 | +16.6% | 0.00% | – |
| Q1 2017 | $4,042,000 | +204.1% | 6,180,624 | +43.4% | 0.00% | – |
| Q4 2016 | $1,329,000 | -62.4% | 4,308,595 | -47.5% | 0.00% | – |
| Q3 2016 | $3,533,000 | +16.8% | 8,214,362 | -1.1% | 0.00% | – |
| Q2 2016 | $3,024,000 | -17.8% | 8,304,524 | -5.1% | 0.00% | – |
| Q1 2016 | $3,679,000 | -50.0% | 8,748,150 | +39.2% | 0.00% | – |
| Q4 2015 | $7,353,000 | +19.8% | 6,284,764 | +4.5% | 0.00% | – |
| Q3 2015 | $6,138,000 | -15.4% | 6,016,852 | +8.6% | 0.00% | – |
| Q2 2015 | $7,254,000 | +0.3% | 5,537,945 | +3.4% | 0.00% | – |
| Q1 2015 | $7,229,000 | +1.6% | 5,355,219 | +4.6% | 0.00% | -100.0% |
| Q4 2014 | $7,118,000 | +3.4% | 5,121,376 | +1.1% | 0.00% | 0.0% |
| Q3 2014 | $6,886,000 | -24.6% | 5,063,620 | +4.2% | 0.00% | 0.0% |
| Q2 2014 | $9,133,000 | +0.9% | 4,857,865 | +2.0% | 0.00% | 0.0% |
| Q1 2014 | $9,052,000 | +55.3% | 4,764,111 | +13.6% | 0.00% | 0.0% |
| Q4 2013 | $5,828,000 | +7.4% | 4,192,531 | +9.0% | 0.00% | 0.0% |
| Q3 2013 | $5,425,000 | +22.8% | 3,847,466 | +12.4% | 0.00% | – |
| Q2 2013 | $4,416,000 | – | 3,423,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|